Clinical Trial Update: Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on topical neuroprotective drugs for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: BCN Peptides | Conditions: Diabetic Retinopathy | Phase 2, Phase 3 | Status: COMPLETED